Abstract
This study describes a multifunctional envelope-type nano device (MEND) that mimics an envelope-type virus based on a novel packaging strategy. MEND particles contain a DNA core packaged into a lipid envelope modified with an octaarginine peptide. The peptide mediates internalization via macropinocytosis, which avoids lysosomal degradation. MEND-mediated transfection of a luciferase expression plasmid achieved comparable efficiency to adenovirus-mediated transfection, with lower associated cytotoxicity. Furthermore, topical application of MEND particles containing constitutively active bone morphogenetic protein (BMP) type IA receptor (caBmpr1a) gene had a significant impact on hair growth in vivo. These data demonstrate that MEND is a promising non-viral gene delivery system that may provide superior results to existing non-viral gene delivery technologies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kamiya H, Tsuchiya H, Yamazaki J, Harashima H . Intracellular trafficking and transgene expression of viral and non-viral gene vectors. Adv Drug Deliv Rev 2001; 52: 153–164.
Khalil IA, Kogure K, Akita H, Harashima H . Uptake pathways and subsequent intracellular trafficking in non-viral gene delivery. Pharm Rev 2006; 58: 32–45.
Zabner J, Fasbender AJ, Moninger T, Poellinger KA, Welsh MJ . Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem 1995; 270: 18997–19007.
Bally MB, Harvie P, Wong FM, Kong S, Wasan EK, Reimer DL . Biological barriers to cellular delivery of lipid-based DNA carriers. Adv Drug Deliv Rev 1999; 38: 291–315.
Ochiai H, Harashima H, Kamiya H . Intranuclear disposition of exogenous DNA in vivo: silencing, methylation and fragmentation. FEBS Lett 2005; 580: 918–922.
Lee RJ, Huang L . Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J Biol Chem 1996; 271: 8481–8487.
Kakudo T, Chaki S, Futaki S, Nakase I, Akaji K, Kawakami T et al. Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system. Biochemistry 2004; 18: 5618–5628.
Zanta MA, Belguise-Valladier P, Behr JP . Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc Natl Acad Sci USA 1999; 96: 91–96.
Kamiya H, Akita H, Harashima H . Pharmacokinetic and pharmacodynamic considerations in gene therapy. Drug Discov Today 2003; 8: 990–996.
Hama S, Akita H, Ito R, Mizuguchi H, Hayakawa T, Harashima H . Quantitative comparison of intracellular trafficking and nuclear transcription between adenoviral and lipoplex systems. Mol Ther 2006; 13: 786–794.
Khalil IA, Kogure K, Futaki S, Harashima H . High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. J Biol Chem 2006; 281: 3544–3551.
Khalil IA, Futaki S, Niwa M, Baba Y, Kaji N, Kamiya H et al. Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation. Gene Ther 2004; 11: 636–644.
Akita H, Khalil IA, Kogure K, Harashima H . Pharmacokinetic considerations in nonviral gene delivery. In: Taira K, Kataoka K, Niidome T (eds). Non-Viral Gene Delivery: Gene Design and Delivery. Springer-Verlag: Tokyo, 2005, pp 135–154.
Kogure K, Akita H, Kamiya H, Harashima H . Programmed packaging: a new drug delivery system and its application to gene therapy. In: Knablein J (ed). Modern Biopharmaceuticals. Design, Development and Optimization, vol. 4. Wiley-VCH: Weinheim pp 1521–1536.
Kogure K, Moriguchi R, Sasaki K, Ueno M, Futaki S, Harashima H . Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method. J Control Release 2004; 98: 317–323.
Farhood H, Serbina N, Huang L . The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim Biophys Acta 1995; 1235: 289–295.
Hafez IM, Cullis PR . Cholesteryl hemisuccinate exhibits pH sensitive polymorphic phase behaviour. Biochim Biophys Acta 2000; 1463: 107–114.
Salone B, Martina Y, Piersanti S, Cundari E, Cherubini G, Franqueville L et al. Integrin alpha3beta1 is an alternative cellular receptor for adenovirus serotype 5. J Virol 2003; 77: 13448–13454.
Plank C, Mechtler K, Szoka Jr FC, Wagner E . Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum Gene Ther 1996; 7: 1437–1446.
Lamaze C, Schmid SL . The emergence of clathrin-independent pinocytic pathways. Curr Opin Cell Biol 1995; 7: 573–580.
Li L, Hoffman RM . The feasibility of targeted selective gene therapy of the hair follicle. Nat Med 1995; 1: 705–706.
Saito N, Zhao M, Li L, Baranov E, Yang M, Ohta Y et al. High efficiency genetic modification of hair follicles and growing hair shafts. Proc Natl Acad Sci USA 2002; 99: 13120–13124.
Domashenko A, Gupta S, Cotsarelis G . Efficient delivery of transgenes to human hair follicle progenitor cells using topical lipoplex. Nat Biotechnol 2000; 18: 420–423.
Yang M, Baranov E, Moossa AR, Penman S, Hoffman RM . Visualizing gene expression by whole-body fluorescence imaging. Proc Natl Acad Sci USA 2000; 97: 12278–12282.
Yuhki M, Yamada M, Kawano M, Iwasato T, Itohara S, Yoshida H et al. BMPR1A signaling is necessary for hair follicle cycling and hair shaft differentiation in mice. Development 2004; 131: 1825–1833.
Kobielak K, Pasolli HA, Alonso L, Polak L, Fuchs E . Defining BMP functions in the hair follicle by conditional ablation of BMP receptor IA. J Cell Biol 2003; 163: 609–623.
Andl T, Ahn K, Kairo A, Chu EY, Wine-Lee L, Reddy ST et al. Epithelial Bmpr1a regulates differentiation and proliferation in postnatal hair follicles and is essential for tooth development. Development 2003; 131: 2257–2268.
Handjiski BK, Eichmuller S, Hofmann U, Czarnetzki BM, Paus R . Alkaline phosphatase activity and localization during the murine hair cycle. Br J Dermatol 1994; 131: 303–310.
Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K et al. Arginine-rich peptides: an abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 2001; 276: 5836–5840.
Wadia JS, Stan RV, Dowdy SF . Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 2004; 10: 310–315.
Nakase I, Niwa M, Takeuchi T, Sonomura K, Kawabata N, Koike Y et al. Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol Ther 2004; 10: 1011–1022.
Kaplan IM, Wadia JS, Dowdy SF . Cationic TAT peptide transduction domain enters cells by macropinocytosis. J Control Release 2005; 102: 247–253.
Swanson JA, Watts C . Macropinocytosis. Trends Cell Biol 1995; 5: 424–428.
Akita H, Ito R, Khalil IA, Futaki S, Harashima H . Quantitative three-dimensional analysis of the intracellular trafficking of plasmid DNA transfected by a nonviral gene delivery system using confocal laser scanning microscopy. Mol Ther 2004; 9: 443–451.
Harris SS, Giorgio TD . Convective flow increases lipoplex delivery rate to in vitro cellular monolayers. Gene Ther 2005; 12: 512–520.
Moriguchi R, Kogure K, Akita H, Futaki S, Miyagishi M, Taira K et al. A multifunctional envelope-type nano device for novel gene delivery of siRNA plasmids. Int J Pharm 2005; 301: 277–285.
Futaki S, Ohashi W, Suzuki T, Niwa M, Tanaka S, Ueda K et al. Stearylated arginine-rich peptides: a new class of transfection systems. Bioconjug Chem 2001; 12: 1005–1011.
Acknowledgements
This work was supported in part by Grants-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, by the MEXT Grant-in-Aid for Young Scientists (B) and Scientific Research on Priority Areas, and by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences. We thank the Hitachi High-Technologies Corporation for generously performing the cryo TEM observation. We thank Drs H Yoshida, Sarah E Millar, Deborah Lang, Carol Trempus and Mitch Eddy for helpful discussions. We also thank Dr Miriam Sander for helpful advice in writing the English manuscript.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Supplementary Information accompanies the paper on Gene Therapy website (http://www.nature.com/gt)
Rights and permissions
About this article
Cite this article
Khalil, I., Kogure, K., Futaki, S. et al. Octaarginine-modified multifunctional envelope-type nanoparticles for gene delivery. Gene Ther 14, 682–689 (2007). https://doi.org/10.1038/sj.gt.3302910
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3302910
Keywords
This article is cited by
-
A potential paradigm in CRISPR/Cas systems delivery: at the crossroad of microalgal gene editing and algal-mediated nanoparticles
Journal of Nanobiotechnology (2023)
-
Comparison of two methods for tumour-targeting peptide modification of liposomes
Acta Pharmacologica Sinica (2023)
-
Vectorization of biomacromolecules into cells using extracellular vesicles with enhanced internalization induced by macropinocytosis
Scientific Reports (2016)
-
Mono-cationic detergents play a critical role in the development of liposome-based gene vector via controlling its lamellarity
Journal of Nanoparticle Research (2014)
-
In Vitro Investigations of the Efficacy of Cyclodextrin-siRNA Complexes Modified with Lipid-PEG-Octaarginine: Towards a Formulation Strategy for Non-viral Neuronal siRNA Delivery
Pharmaceutical Research (2013)